Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy

Completed

Conditions studied: Pulmonary Disease, Chronic Obstructive

In brief

A multicenter study to evaluate lung function and symptoms in subjects with COPD who have been on regular use of only one long-acting bronchodilator.

Key facts

Study ID

NCT00791518

Run by

GlaxoSmithKline

People needed

1084

Starts

2008-12-01

Expected to finish

2009-05-01

Last updated by the study team

2014-07-30

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Cigarette smoking history-Current or ex-smokers (defined as stopped smoking for at least three months prior to the study visit)
• Established history of COPD as diagnosed by a physician
• Regular use (prescribed for use every day) of only one long-acting bronchodilator greater than or equal to one month before the study visit
• Ability to read, comprehend, and record information in the English language

You may not qualify if…

• Currently active asthma (receiving asthma therapy and or having asthma symptoms)
• Use of ipratropium/albuterol combination products greater than three times per day, use of inhaled corticosteroids, use of inhaled corticosteroid/long-acting beta-agonist combinations, theophylline preparations, or oral beta agonists within 3 months prior to the study visit
• Previous lung surgery
• Other respiratory disorders other than COPD
• Current alcohol, illegal drug, or solvent abuse
• Females with a positive urine pregnancy test at the study visit

Where it is running

• GSK Investigational Site — Tucson, Arizona, United States
• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — National City, California, United States
• GSK Investigational Site — Rancho Mirage, California, United States
• GSK Investigational Site — Riverside, California, United States
• GSK Investigational Site — Santa Ana, California, United States
• GSK Investigational Site — Walnut Creek, California, United States
• GSK Investigational Site — Colorado Springs, Colorado, United States
• GSK Investigational Site — Colorado Springs, Colorado, United States
• GSK Investigational Site — Stamford, Connecticut, United States
• GSK Investigational Site — Cocoa, Florida, United States
• GSK Investigational Site — DeLand, Florida, United States
• GSK Investigational Site — Largo, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Naranja, Florida, United States
• GSK Investigational Site — South Miami, Florida, United States
• GSK Investigational Site — Tamarac, Florida, United States
• GSK Investigational Site — Tampa, Florida, United States
• GSK Investigational Site — Winter Park, Florida, United States
• GSK Investigational Site — Evansville, Indiana, United States
• GSK Investigational Site — Indianapolis, Indiana, United States
• GSK Investigational Site — New Orleans, Louisiana, United States
• GSK Investigational Site — Sunset, Louisiana, United States
• GSK Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.